All News

An easy-to-administer urine test looking for telomerase reverse transcriptase mutations helps detect recurring urothelial bladder cancer, especially non-muscle-invasive bladder cancer, early on, according to a new study.

Urology Times reached out to three urologists (selected randomly and asked them each the following question: How will immunotherapy change the future of bladder Ca care?

The chances of needing long-term disability insurance are higher than you might think and can be worth the expense

A quasi-randomized trial of open versus robotic radical prostatectomy and an evaluation of robotic inferior vena cava thrombectomy were among other key minimally invasive surgery studies at the AUA annual meeting in Boston.

"Urology providers and caregivers can serve as the primary venue for positively impacting both the psychological and physical components of men’s health as men trust us with their most intimate and personal issues of life," writes SUNA President Gwendolyn Hooper, PhD, APRN.

An updated guideline on localized kidney cancer as well as a look at active surveillance as initial management for renal masses <2 cm were among the noteworthy kidney cancer studies at the AUA annual meeting in Boston.

A study documenting that male paternal age is increasing across the U.S. and a finding that men with Sertoli cell-only syndrome have increased damage to seminiferous tubules with aging are among the take-homes in infertility/andrology at the AUA annual meeting in Boston.

Other products discussed include cancer tests, an app to connect patients with specialists, a revenue management system, and more

A report on the Global Kidney Exchange and the finding that robot-assisted reconstruction of the transplant ureter is feasible were among the noteworthy research in transplantation at the AUA annual meeting in Boston.

A study that found that age was more strongly associated with selection of colpocleisis than frailty and a comparison of two common wide pore polypropylene Y meshes were among the noteworthy female urology/incontinence research at the AUA annual meeting in Boston.

Other infection/inflammation take-home messages from the AUA annual meeting include a study of predictors of fluoroquinolone resistance in the rectal vault of men undergoing prostate biopsy and a study of 1,310 patients evaluated over 16 years for CP/CPPS.

A prospective evaluation of cancer detection rates with PI-RADS and the finding that use of micro-computed tomography enabled rapid phenotyping of GU anomalies in adult and embryonic mice were among other key imaging studies from the AUA annual meeting.

A comparison of four methods for evaluating microhematuria and an evaluation of a value-based care pathway for men undergoing surgery for BPH were among other noteworthy AUA 2017 in the area of outcomes.

Other AUA 2017 take-home messages in sexual dysfunction included a study indicating that obstructive sleep apnea correlated with increased venous leak as well as a finding that wounded veterans from Iraq and Afghanistan with genitourinary injuries had higher injury severity scores and were more likely to have urinary and sexual dysfunction than those without GU injuries.

For suspected low-grade, newly diagnosed, or occasionally recurrent bladder cancer, a single post-transurethral resection of bladder tumor instillation of gemcitabine (Gemzar) reduces bladder cancer recurrence by 47%, according to a recent study.

Evaluation of upper tract surveillance for high-grade, nonmuscle-invasive bladder cancer and evidence suggesting that androgen receptor activity may be related to recurrence and treatment of bladder cancer were among the take-home messages in this area from AUA 2017.

The finding that the glans is a significant variable in hypospadias complications and an evaluation of external pelvic fixation alone without osteotomy at time of newborn bladder exstrophy closure were among the noteworthy studies in pediatric urology at AUA 2017.

The AUA 2017 Quality Improvement and Patient Safety take-home messages also highlighted a QI project that led to reductions in catheter trauma rates and a QI program for robot-assisted radical prostatectomy that uses video clips.

Studies of bipolar plasma vaporization of the prostate and thulium vapoenucleation were among the other noteworthy research in BPH/LUTS presented at the AUA annual meeting in Boston.

Other take-home messages in penile/urethral cancer included discussion of proposed 2018 AJCC penile cancer guidelines as well as the finding that in women with primary urethral cancer, adenocarcinoma was the most common pathology.

Telemedicine may provide urologists with enhanced care and unique benefits-or risks-depending on the specifics of the laws that pass.

As the Republican-led Congress wrestles with the daunting challenge of developing comprehensive health care legislation to replace the Affordable Care Act, specialty organizations-including those representing urology-are working to influence the ultimate outcome.

Transrectal saturation biopsy resulted in higher rates of disease reclassification compared with magnetic resonance (MR) fusion biopsy plus extended sextant prostate biopsy in patients with low-risk prostate cancer on active surveillance.

In this interview, newly elected AUA President J. Brantley Thrasher, MD, discusses the organization’s expanded efforts in advocacy, research, and education.

Maternal postpartum depression (PPD) is a widely studied and discussed phenomenon, whereas much less is known about the concept of paternal PPD. Nonetheless, recent studies have indicated that depression in new fathers is a significant public health concern.

Informed consent in medicine generally refers to one of two things: the process by which a provider obtains consent through discussion of risks, benefits, and alternatives with patients, and the actual form that is signed by the physician and the patient. Both are critical pieces to any medical malpractice litigation where a claim for lack of informed consent has been pled.

A study aimed at further elucidating the mechanism of action of sipuleucel-T (Provenge) in advanced prostate cancer provides fairly convincing evidence that the immunotherapy agent induces T-cell responses in humans, says Charles G. Drake, MD, PhD.

Patients newly diagnosed with prostate cancer show race-related differences in what men perceive as important factors in their treatment decision-making process.